Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population

Gynecologic and Obstetric Investigation

Volumn 65, Issue 1, 2008, Pages 68-72

  Delgado Enciso, Iván ^a,c   Cepeda Lopez, Friedman R ^b   Monrroy Guizar, Elisa A ^a   Bautista Lam, Jose R ^a   Andrade Soto, Maricela ^a   Jonguitud Olguin, Gregorio ^b   Rodriguez Hernandez, Alejandrina ^a   Anaya Ventura, Aristoteles ^a   Baltazar Rodriguez, Luz M ^a   Orozco Ruiz, Martha ^b   Soriano Hernandez, Alejandro D ^a   Rodriguez Sanchez, Iram P ^a   Lugo Trampe, Angel ^a   Espinoza Gomez, Francisco ^a   Michel Peregrina, Martha L ^a  

^a UNIVERSIDAD DE COLIMA   (Mexico)

^b Secretaria de Salud del Estado de Colima   (Mexico)

^c Universidad de Colima   (Mexico)

Author keywords

Breast tumor; Gelatinase A; Matrix metalloproteinase; Mexico; Polymorphism; Promoter

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; MATRIX METALLOPROTEINASE 2 CC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEXICO; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 2; MEXICAN AMERICANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 38349093274     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108282     Document Type: Article

References (25)

1. Stamenkovic I: Matrix metallproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10:415-433.
2. Curran S, Murray GI: Matrix metallproteinases in tumor invasion and metastasis. J. Pathol 1999;189:300-308.
3. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174.
4. Pacheco MM, Mourao M, Mantovani EB, Nishimoto IN, Brentani MM: Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinicopathological correlations. Clin Exp Metastasis 1998;16:577-585.
5. Lebeau A, Muller-Aufdemkamp C, Allmacher C, et al: Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth. J Mol Histol 2004;35:443-455.
6. Hirvonen R, Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T: Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma. Breast Cancer Res Treat 2003;77:85-91.
7. Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T: Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br J Cancer 2003;89:1270-1275.
8. Talvensaari-Mattila A, Paakko P, Blanco-Sequeiros G, Turpeenniemi-Hujanen T: Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. Breast Cancer Res Treat 2001;65:55-61.
9. Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T: MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with nodepositive breast carcinoma. Breast Cancer Res Treat 1999;58:287-293.
10. Leppa S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I: A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res 2004;10:1057-1063.
11. La Rocca GL, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S: Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer 2004;90:1414-1421.
12. Price SJ, Greaves DR, Watkins H: Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001;276:7549-7558.
13. Grieu F, Li WQ, Iacopetta B: Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 2004;88:197-204.
14. Zhou Y, Yu C, Miao X, et al: Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 2004;25:399-404.
15. Roehe AV, Frazzon AP, Agnes G, Damin AP, Hartman AA, Graudenz MS: Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat 2007;102:123-124.
16. Sobin LH, Wittekind C: TNM Classification of Malignant Tumors, ed 5. New York, Wiley-Liss, 1997.
17. Yu C, Pan K, Xing D, et al: Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 2002;62:6430-6433.
18. Miao X, Yu C, Tan W, et al: A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003;63:3987-3990.
19. Xu EP, Huang Q, Lu BJ, Xing XM, Lai MD: The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006;23:78-81.
20. Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW: Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004;33:405-409.
21. Elander N, Soderkvist P, Fransen K: Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 2006;26:791-795.
22. Rollin J, Regina S, Vourc'h P, Iochmann S, Blechet C, Reverdiau P, Gruel Y: Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer 2007;56:273-280.
23. Hettiaratchi A, Hawkins NJ, McKenzie G, Ward RL, Hunt JE, Wakefield D, Di Girolamo N: The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer 2007;96:783-792.
24. Lahman C, Bergemann J, Harrison G, Young AR: Matrix metalloproteinase-1 and skin ageing in smokers. Lancet 2001;357:935-936.
25. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L: Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002;67:889-894.